Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
Guardado en:
Autores principales: | Martin A. Redhead, C. David Owen, Lennart Brewitz, Amelia H. Collette, Petra Lukacik, Claire Strain-Damerell, Sean W. Robinson, Patrick M. Collins, Philipp Schäfer, Mark Swindells, Chris J. Radoux, Iva Navratilova Hopkins, Daren Fearon, Alice Douangamath, Frank von Delft, Tika R. Malla, Laura Vangeel, Thomas Vercruysse, Jan Thibaut, Pieter Leyssen, Tu-Trinh Nguyen, Mitchell Hull, Anthony Tumber, David J. Hallett, Christopher J. Schofield, David I. Stuart, Andrew L. Hopkins, Martin A. Walsh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ac2cac0657547338f504a11bf010e33 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Martin A. Redhead, et al.
Publicado: (2021) -
2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases
por: Yu Nakashima, et al.
Publicado: (2021) -
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
por: Joseph A. Newman, et al.
Publicado: (2021) -
Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Lennart Brewitz, et al.
Publicado: (2020) -
Author Correction: Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Lennart Brewitz, et al.
Publicado: (2020)